Home CellSeed

CellSeed

In operation
IPO
Regenerative Medicine Developer
Basic
Enterprise Profile

Basic Information

CellSeed Inc. primarily develops regenerative medical products in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheets for corneal and esophageal regeneration, regenerative cardiac patches for heart disease treatment, cell sheets for periodontal tissue regeneration, and regenerative cartilage sheets for osteoarthritis treatment.
CellSeed Inc.
Tokyo,Tokyo,Japan
15~50 people
May 09, 2001
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Orthopedics Ophthalmology Cardiovascular Disease
Application Scenarios
Biologics Innovative Drugs